MultiBiopsy ApS: Financial statements 2025
CVR: 44304554
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MultiBiopsy ApS (CVR 44304554) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 527,728 and a net result of DKK -2,337. Equity in the 2025 report amounted to DKK 63,703. The solvency ratio was 18%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 527,728
- Profit/Loss
- DKK -2,337
- Equity
- DKK 63,703
- Total Assets
- DKK 353,006
- Employees
- 4
Official annual report
How creditworthy is MultiBiopsy ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 13, 2025, William Hans Jul Vindal Ludvigsen is registered as director of MultiBiopsy ApS.
As of October 13, 2025, Kristian Horsager has stepped down as director of MultiBiopsy ApS.
MultiBiopsy ApS has published its interim report for the period September 12, 2023 – December 31, 2024.
About MultiBiopsy ApS
MultiBiopsy ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2023. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of William Hans Jul Vindal Ludvigsen. The company is owned by MultiBiopsy Holding ApS. According to the 2025 annual report, the company had an average of 4 employees. In 2025, the company reported a gross profit of DKK 527,728 and a net result of DKK -2,337. Equity in the 2025 report amounted to DKK 63,703.